O'Boyle B, Yeung W, Lu JD, Katiyar S, Yaron-Barir TM, Johnson JL, Cantley LC, Kannan N.
2025.
An atlas of bacterial serine-threonine kinases reveals functional diversity and key distinctions from eukaryotic kinases.. Sci Signal. 18(885):eadt8686.
Khosravi P, Saikali S, Alipour A, Mohammadi S, Boger M, Diallo DM, Smith CJ, Moschovas MC, Hajirasouliha I, Hung AJ et al..
2025.
AutoRadAI: a versatile artificial intelligence framework validated for detecting extracapsular extension in prostate cancer.. Biol Methods Protoc. 10(1):bpaf032.
Moothedan E, Boyer M, Watts S, Abdel-Aty Y, Ghosh S, Rameau A, Sigaras A, Elemento O, Bensoussan Y.
2025.
The Bridge2AI-voice application: initial feasibility study of voice data acquisition through mobile health.. Front Digit Health. 7:1514971.
Borea R, Saldanha EF, Maheswaran S, Nicolo E, Singhal S, Pontolillo L, Perez Dde Miguel, Venetis K, Dipasquale A, Ghazali N et al..
2025.
Cancer in a drop: Advances in liquid biopsy in 2024.. Crit Rev Oncol Hematol. 213:104776.
Agarwal PK, Sternberg CN.
2025.
Clinical trials corner issue 11(1).. Bladder Cancer. 11(1):23523735241309418.
Nauseef JT, Chu TR, Hooper WF, Alonso A, Oku A, Geiger H, Goldstein ZR, Shah M, Sigouros M, Manohar J et al..
2025.
A complex phylogeny of lineage plasticity in metastatic castration resistant prostate cancer.. NPJ Precis Oncol. 9(1):91.
Neth BJ, Huynh K, Giles C, Wang T, Mellett NA, Duong T, Blach C, Schimmel L, Register TC, Blennow K et al..
2025.
Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans.. Commun Med (Lond). 5(1):11.
Chew SMei, Teumer A, Matías-García PR, Gieger C, Winckelmann J, Suhre K, Herder C, Rathmann W, Peters A, Waldenberger M.
2025.
Cross-sectional and longitudinal association of seven DNAm-based predictors with metabolic syndrome and type 2 diabetes.. Clin Epigenetics. 17(1):58.
Claridge SE, Nath S, Baum A, Farias R, Cavallo J-A, Rizvi NM, De Boni L, Park E, Granados GLara, Hauesgen M et al..
2025.
Functional genomics pipeline identifies CRL4 inhibition for the treatment of ovarian cancer.. Clin Transl Med. 15(2):e70078.